Sanjeev K. Srivastava's most recent trade in Bright Health Group Inc was a trade of 478,851 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on March 7, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bright Health Group Inc | Sanjeev K. Srivastava | CEO, NEUEHEALTH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 478,851 | 478,851 | - | - | Stock Options (Right to Buy) | |
Bright Health Group Inc | Sanjeev K. Srivastava | CEO, NEUEHEALTH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 251,397 | 251,397 | - | - | Restricted Stock Units | |
Bright Health Group Inc | Sanjeev K. Srivastava | CEO, NEUEHEALTH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 1,200,000 | 1,200,000 | - | - | Restricted Stock Units | |
Bright Health Group Inc | Sanjeev K. Srivastava | CEO, NEUEHEALTH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,050,000 | 1,050,000 | - | - | Restricted Stock Units | |
Bright Health Group Inc | Sanjeev K. Srivastava | CEO, NEUEHEALTH | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2021 | 593,748 | 906,252 | - | - | Stock Options (Right to Buy) | |
Bright Health Group Inc | Sanjeev K. Srivastava | CEO, NEUEHEALTH | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.77 per share. | 06 May 2021 | 593,748 | 593,748 | - | 1.8 | 1,052,715 | Common Stock |
Bright Health Group Inc | Sanjeev K. Srivastava | CEO, NEUEHEALTH | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.77 per share. | 06 May 2021 | 27,180 | 620,928 | - | 1.8 | 48,190 | Common Stock |
Bright Health Group Inc | Sanjeev K. Srivastava | CEO, NEUEHEALTH | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2021 | 27,180 | 41,487 | - | - | Stock Options (Right to Buy) |